Ogimoto T, Ozasa H, Tsuji T, Funazo T, et al. Combination therapy with EGFR tyrosine kinase inhibitors and TEAD inhibitor increases tumor suppression effects in EGFR mutation-positive lung cancer. Mol Cancer Ther 2023 Dec 6. doi: 10.1158/1535-7163.MCT-23-0371.
PMID: 38052760